25Aug 2023
Serine protease inhibitors decrease metastasis in prostate, breast and ovarian cancers

Serine protease inhibitors decrease metastasis in prostate, breast and ovarian cancers

This study explores innovative targeted therapies for advanced prostate, breast, and ovarian cancers using mesotrypsin and KLK6 proteases and help learn about novel APPI mutants (APPI-3M and APPI-4M) with therapeutic and imaging potential, including their favorable attributes for efficacy, safety, and manufacturability, supporting their role in tackling metastatic cancer.

  • #oncology

Like

Save

Share